Literature DB >> 25650692

Microbiologic profile of Staphylococci isolated from osteoarticular infections: evolution over ten years.

Marie Titécat1, Eric Senneville, Frédéric Wallet, Hervé Dezèque, Henri Migaud, René J Courcol, Caroline Loïez.   

Abstract

BACKGROUND: Staphylococci, especially coagulase-negative staphylococci (CoNS) represent the most frequent micro-organism associated with osteoarticular infections (OAIs), especially those involving orthopedic devices. The antibiotic susceptibility profile of the bacteria mostly responsible for OAIs is therefore crucial information for choosing the appropriate antibiotic regimen administered during the removal procedure until the first results of the conventional culture.
METHODS: The antibiotic susceptibility profile of staphylococci isolated from OAIs in a referent center for osteoarticular infection was studied over a 10-y period to adapt antibiotic protocols to the ecology.
RESULTS: From 2002 to 2011, the resistance of Staphylococcus aureus to methicillin and rifampicin decreased (27.9% versus 20.6% and 13% versus 1%, respectively); the resistance to fluoroquinolones (FQ) was stable (24% on average), and all the isolates were susceptible to glycopeptides. For CoNS, the resistance to methicillin, rifampicin, and FQ increased (30.4% versus 43.9%, 13% versus 18.5%, and 20.3% versus 34.1%, respectively) over the same period. Resistance of the CoNS to vancomycin was observed in 2011 for the first time (2.3%), and 3.8% were resistant to teicoplanin in 2002 compared with 22% in 2011, with 3.5% resistant to linezolid in 2011.
CONCLUSION: The sensibility of bacteria over 10 y remained stable, except for CoNS. The increase of the resistances for CoNS led us to exclude teicoplanin from the first-line empiric antibiotic treatment, to avoid linezolid, and to prefer vancomycin or daptomycin.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25650692     DOI: 10.1089/sur.2013.258

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  5 in total

1.  Prospective Cohort Study of the Tolerability of Prosthetic Joint Infection Empirical Antimicrobial Therapy.

Authors:  Claire Triffault-Fillit; Florent Valour; Ronan Guillo; Michel Tod; Sylvain Goutelle; Sébastien Lustig; Michel-Henry Fessy; Christian Chidiac; Tristan Ferry
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

2.  Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.

Authors:  Olivier Peeters; Tristan Ferry; Florence Ader; André Boibieux; Evelyne Braun; Anissa Bouaziz; Judith Karsenty; Emmanuel Forestier; Frédéric Laurent; Sébastien Lustig; Christian Chidiac; Florent Valour
Journal:  BMC Infect Dis       Date:  2016-11-03       Impact factor: 3.090

3.  Economic Study of 2-Stage Exchange in Patients With Knee or Hip Prosthetic Joint Infection Managed in a Referral Center in France: Time to Use Innovative(s) Intervention(s) at the Time of Reimplantation to Reduce the Risk of Superinfection.

Authors:  Hassan Serrier; Christell Julien; Cécile Batailler; Eugénie Mabrut; Corinne Brochier; Sylvie Thevenon; Marianne Maynard-Muet; Agnes Henry; Sébastien Lustig; Laure Huot; Tristan Ferry
Journal:  Front Med (Lausanne)       Date:  2021-05-10

4.  Antibiotic sensitivities of coagulase-negative staphylococci and Staphylococcus aureus in hip and knee periprosthetic joint infections: does this differ if patients meet the International Consensus Meeting Criteria?

Authors:  Elena De Vecchi; David A George; Carlo L Romanò; Fabrizio E Pregliasco; Roberto Mattina; Lorenzo Drago
Journal:  Infect Drug Resist       Date:  2018-04-13       Impact factor: 4.003

Review 5.  Model-Informed Precision Dosing of Antibiotics in Osteoarticular Infections.

Authors:  Lingling Liu; Jin Wang; Huan Zhang; Mengli Chen; Yun Cai
Journal:  Infect Drug Resist       Date:  2022-01-11       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.